The aim of this study is to look at the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a therapeutic intervention for patients with schizophrenia. The primary outcome is improvement in negative symptoms related to schizophrenia. The investigators are focusing on negative symptoms given their greater resistance to pharmacological and other established therapies. If the investigators trial were to show beneficial effects, its clinical significance would be great.
- Age between 18-65 years
- Diagnosis of schizophrenia according to DSM-IV criteria (by a board-certified psychiatrist)
Boston, Beth Israel Deaconess Medical Center